Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although numerous biological functions of the activating transcription factor 4 (ATF4) have been identified, a direct effect of ATF4 on alcoholic liver steatosis has not been described previously. The aim of our current study is to investigate the role of ATF4 in alcoholic liver steatosis and elucidate the underlying mechanisms. Here, we showed that the expression of ATF4 is induced by ethanol in hepatocytes in vitro and in vivo, and liver-specific ATF4 knock-out mice are resistant to ethanol-induced liver steatosis, associated with stimulated hepatic
AMP-activated protein kinase
(
AMPK
) activity. Furthermore, adenovirus-mediated
AMPK
knockdown significantly reversed the suppressive effects of ATF4 deficiency on ethanol-induced liver steatosis in mice. In addition, ethanol-fed ATF4 knock-out mice exhibit
AMPK
-dependent inhibition of fatty acid synthase and stimulation of carnitine palmitoyltransferase 1 (CPT1) in the liver. Moreover, hepatic
Tribbles homolog 3
(
TRB3
) expression was stimulated by ethanol in an ATF4-dependent manner, and adenovirus-mediated
TRB3
knockdown blocked ATF4-dependent ethanol-induced
AMPK
inhibition and triglyceride accumulation in AML-12 cells. Finally,
TRB3
directly interacted with
AMPK
to suppress its phosphorylation. Taken together, these results identify the ATF4-
TRB3
-
AMPK
axis as a novel pathway responsible for ethanol-induced liver steatosis.
...
PMID:Liver-specific Gene Inactivation of the Transcription Factor ATF4 Alleviates Alcoholic Liver Steatosis in Mice. 2740 64
Our previous study had suggested
Tribbles homolog 3
(
TRB3
) might be involved in metabolic syndrome via adipose tissue. Given prior studies, we sought to determine whether
TRB3
plays a major role in adipocytes and adipose tissue with beneficial metabolic effects in obese and diabetic rats. Fully differentiated 3T3-L1 adipocytes were incubated to induce insulin resistant adipocytes. Forty male Sprague-Dawley rats were all fed high-fat (HF) diet. Type 2 diabetic rat model was induced by high-fat diet and low-dose streptozotocin (STZ). Compared with control group, in insulin resistant adipocytes, protein levels of insulin receptor substrate-1(IRS-1), glucose transporter 4(GLUT4) and phosphorylated-
AMP-activated protein kinase
(p-AMPK)were reduced,
TRB3 protein
level and triglyceride level were significantly increased, glucose uptake was markedly decreased.
TRB3
silencing alleviated adipocytes insulin resistance. With
TRB3
gene silencing, protein levels of IRS-1, GLUT4 and p-
AMPK
were significantly increased in adipocytes.
TRB3
gene silencing decreased blood glucose, ameliorated insulin sensitivity and adipose tissue remodeling in diabetic rats.
TRB3
silencing decreased triglyceride, increased glycogen simultaneously in diabetic epididymal and brown adipose tissues (BAT). Consistently, p-
AMPK
levels were increased in diabetic epididymal adipose tissue, and BAT after
TRB3
-siRNA treatment. TRB3silencing increased phosphorylation of Akt in liver, and improved liver insulin resistance.
...
PMID:TRB3 gene silencing activates AMPK in adipose tissue with beneficial metabolic effects in obese and diabetic rats. 2847 19